1. Home
  2. PTGX vs KAI Comparison

PTGX vs KAI Comparison

Compare PTGX & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • KAI
  • Stock Information
  • Founded
  • PTGX 2006
  • KAI 1991
  • Country
  • PTGX United States
  • KAI United States
  • Employees
  • PTGX N/A
  • KAI N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • KAI Industrial Machinery/Components
  • Sector
  • PTGX Health Care
  • KAI Industrials
  • Exchange
  • PTGX Nasdaq
  • KAI Nasdaq
  • Market Cap
  • PTGX 4.0B
  • KAI 3.6B
  • IPO Year
  • PTGX 2016
  • KAI N/A
  • Fundamental
  • Price
  • PTGX $76.75
  • KAI $299.66
  • Analyst Decision
  • PTGX Strong Buy
  • KAI Buy
  • Analyst Count
  • PTGX 9
  • KAI 2
  • Target Price
  • PTGX $78.11
  • KAI $340.00
  • AVG Volume (30 Days)
  • PTGX 1.5M
  • KAI 151.6K
  • Earning Date
  • PTGX 10-31-2025
  • KAI 10-28-2025
  • Dividend Yield
  • PTGX N/A
  • KAI 0.45%
  • EPS Growth
  • PTGX N/A
  • KAI N/A
  • EPS
  • PTGX 0.80
  • KAI 8.65
  • Revenue
  • PTGX $209,180,000.00
  • KAI $1,024,074,000.00
  • Revenue This Year
  • PTGX N/A
  • KAI N/A
  • Revenue Next Year
  • PTGX $142.86
  • KAI $5.10
  • P/E Ratio
  • PTGX $95.33
  • KAI $34.78
  • Revenue Growth
  • PTGX N/A
  • KAI N/A
  • 52 Week Low
  • PTGX $33.31
  • KAI $270.73
  • 52 Week High
  • PTGX $93.25
  • KAI $429.95
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 59.19
  • KAI 49.52
  • Support Level
  • PTGX $73.08
  • KAI $284.40
  • Resistance Level
  • PTGX $79.00
  • KAI $312.46
  • Average True Range (ATR)
  • PTGX 2.93
  • KAI 10.61
  • MACD
  • PTGX -0.37
  • KAI 1.69
  • Stochastic Oscillator
  • PTGX 27.14
  • KAI 67.93

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: